{"entity":{"id":"adimab","kind":"company","name":"Adimab","aka":[],"tldr":"Adimab discovers and engineers antibodies for drug developers, including partners developing cancer medicines.","summary":"Adimab is an antibody discovery and engineering company. Ono Pharmaceutical announced a collaboration with Adimab to discover and develop antibody drugs in oncology. The agreement covers discovery against targets selected by Ono; Ono will evaluate and develop candidates and has an option to obtain exclusive rights to develop, manufacture and commercialise them worldwide. This is a research partnership, not evidence that an antibody from it improves cancer outcomes.","asOf":"2026-11-06","links":[{"label":"Ono oncology antibody collaboration","url":"https://www.ono-pharma.com/en/news/20230927.html"},{"label":"Official location evidence","url":"https://www.ono-pharma.com/en/news/20230927.html"},{"label":"Elicit AI for Pharma market map","url":"https://elicit.com/ai-for-pharma"}],"tags":[],"related":[],"cancers":[],"sections":["drug-discovery"],"technologies":[],"targets":[],"drugs":[],"companies":[],"institutions":[],"pathways":[],"terms":[],"trials":[],"people":[],"bottlenecks":[],"keyPapers":[],"journals":[],"dependsOn":[],"notes":["Location is stated in Ono's announcement."],"hq":"Lebanon, NH","country":"US","companyType":"biotech","website":"https://adimab.com/","investors":[],"funding":[]},"route":"/companies/adimab/","neighbours":{"section":[{"id":"drug-discovery","kind":"section","name":"Drug Discovery Platforms","route":"/fronts/drug-discovery/"}],"collection":[{"id":"elicit-ai-for-pharma","kind":"collection","name":"Elicit AI for Pharma market map","route":"/collections/elicit-ai-for-pharma/"}]}}